P2.146 CD4 Lymphocytes Count At First Presentation of HIV Positive Patients Accessing Antiretroviral Therapy At a District...
... with CD4 count of less than 100 cells/mm3, 24.7% (218/883) with CD4 count of less than 250 cells/mm3, 16.0% (141/883) with CD4 ... Less than a quarter (18.8%, 116/883) of patients came with CD4 count of 500 cells/mm3 or more. 70.9% came with CD4 count of ... of all HIV positive patients presented with CD4 count of less than 250 cells/mm3. 20.7% (183/883) reported with CD4 count less ... P2.146 CD4 Lymphocytes Count At First Presentation of HIV Positive Patients Accessing Antiretroviral Therapy At a District ...http://sti.bmj.com/content/89/Suppl_1/A132.3
Evaluation of a Low-Cost Strategy for Enumerating CD4 Lymphocyte Absolute Count and Percentage Using the FACSCalibur Flow...
Evaluation of a Low-Cost Strategy for Enumerating CD4 Lymphocyte Absolute Count and Percentage Using the FACSCalibur Flow ... D. Barnett, B. Walker, A. Landay, and T. N. Denny, "CD4 immunophenotyping in HIV infection," Nature Reviews Microbiology, vol. ... T. Peter, A. Badrichani, E. Wu et al., "Challenges in implementing CD4 testing in resource-limited settings," Cytometry B, vol ... "Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: an approach to improve accessibility for HIV ...https://www.hindawi.com/journals/isrn/2012/494698/ref/
U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected...
HIV-infected adults with 1 or more HIV RNA plasma viral load (HIV VL) or CD4 T-lymphocyte (CD4) cell count measured in any ... U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected ... U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected ... A clinical decision-support system with interactive alerts improved CD4 cell count in HIV Annals of Internal Medicine; 158 (8): ...http://annals.org/aim/article-abstract/1355684/u-s-trends-antiretroviral-therapy-use-hiv-rna-plasma-viral
JCDR - Absolute Lymphocyte Count as a Surrogate Marker of CD4 Count in Monitoring HIV Infected Individuals: A...
Absolute Lymphocyte Count as a Surrogate Marker of CD4 Count in Monitoring HIV Infected Individuals: A Prospective Study EC17- ... Introduction: CD4 cell count has been proposed to be substituted by Absolute lymphocyte count in monitoring HIV infected ... To assess the clinical utility of the Absolute Lymphocyte Count (ALC) to serve as a surrogate marker for predicting a CD4 count ... revealed good correlation between ALC and CD4 cell counts but ALC cut-off of 1200 was not a surrogate marker for CD4 cell count ...http://www.jcdr.net/article_abstract.asp?issn=0973-709x&year=2016&volume=10&issue=5&page=EC17&issn=0973-709x&id=7765
Association between CD4+ Lymphocyte Count and Left Ventricular Diastolic Function and Geometry in Newly Diagnosed Highly...
Correlation of CD4+lymphocyte count with clinical and echocardiograghic parameters. A correlation study of CD4+ lymphocyte ... CD4 count ,200 cells/μl) were 1.68 times more likely to develop diastolic dysfunction than cases without AIDS (CD4 count ,200 ... There was an insignificant negative correlation between CD4 + count and IVRT (R=- 0.0086, P=0.393). Subjects with CD4 + count , ... there was an insignificant negative correlation between CD4 + count and LVMI (R=- 0.303, P=0.816). Subjects with CD4 + count, ...https://www.omicsonline.org/open-access/association-between-cd4-lymphocyte-count-and-left-ventricular-diastolicfunction-and-geometry-in-newly-diagnosed-highly-active-anti-2329-9517-1000295.php?aid=94131
Publications | AIDS Clinical Trials Group
CD4 Lymphocyte Count. Markowitz M, Vaida F, C Hare B, et al. "The virologic and immunologic effects of cyclosporine as an ...https://actgnetwork.org/pubmed_publications?s=keyword&o=asc&f%5Bauthor%5D=136
Combination antiretroviral therapy and th... & related info | Mendeley
CD4 Lymphocyte Count. *Combination. *Drug Therapy. *Female. *Follow-Up Studies. *HIV Infections/*complications/drug therapy ...https://www.mendeley.com/research-papers/combination-antiretroviral-therapy-risk-myocardial-infarction-43/
A Study of a Combination of Four Drugs in Patients With Recent HIV Infection - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Viral Load. Additional relevant MeSH terms: ... patients undergo physical assessments and efficacy evaluations which include plasma HIV-1 RNA measurements and CD4 cell counts ... A clinical diagnosis of AIDS, excluding CD4+ cell counts less than 200/mm3. ...https://clinicaltrials.gov/show/NCT00002233?order=107
A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance...
CD4 Lymphocyte Count. Ritonavir. Lamivudine. Indinavir. RNA, Viral. Genotype. Reverse Transcriptase Inhibitors. Anti-HIV Agents ... Each of the four strata contains 22 patients with CD4+ counts of 50 - 199/mm3 and 11 patients with CD4+ counts of 200 - 500/mm3 ... Documentation of a CD4+ cell count between 50 and 500/mm3 prior to the baseline visit [within 6 weeks prior to baseline visit ... d4T/3TC/IDV) and screening CD4+ count (50-199 vs. 200-500). Management of patients assigned to the GART group is based on ...https://clinicaltrials.gov/show/NCT00000874?order=580
Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 - Full...
Intermittently administered IL-2 in the presence of HAART has been shown to increase CD4 cell counts, decrease lymphocyte ... Patients are monitored for CD4 counts at bimonthly intervals after the first IL-2 dose. CD4 counts and plasma storage for HIV ... Patients in Arms II or III of ACTG 328 (IL-2-containing arms) who have had a 25 percent or greater increase in CD4 cell count ... Have had a 25 percent or greater increase in CD4 cell count above the ACTG 328 Week 11 value (only applies to patients who ...https://clinicaltrials.gov/show/NCT00000923?order=379
A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine...
CD4+lymphocyte count; full blood count; biochemistry; lipid parameters [ Time Frame: Week 48 and 96 ]. *glycaemic parameters; ...https://clinicaltrials.gov/show/NCT00192634?order=231
A Study of Two Anti-HIV Drug Combinations - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. CD4-CD8 Ratio. Lamivudine. Patient Compliance. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Viral ...https://clinicaltrials.gov/ct2/show/NCT00002203
Observing Patients With Early HIV Infection - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. CD4-Positive T-Lymphocytes. Phenotype. Viral Load. Acute Infection. ... The first is that CD4 target cell numbers are depleted, so the reduction in permissive target cells limits viral replication. A ... second is that the host develops an HIV-specific cytotoxic T lymphocyte (CTL) immune response that limits viral replication ...https://clinicaltrials.gov/show/NCT00005020?order=293
Increasing HAART-Induced Immune Restoration With Cyclosporine - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Lamivudine. Cyclosporine. Hepatitis A Vaccine. Rabies Vaccine. abacavir. Antiretroviral Therapy, Highly ... To ascertain whether the augmentation in the rise in CD4 lymphocytes is sustained, the number of circulating CD4 lymphocytes 48 ... Have a CD4 cell count greater than 100 cells/mm3 within 30 days prior to study entry. ... There are, however, several potential methods that can be used that possibly may enhance the magnitude of CD4 lymphocyte rise ...https://clinicaltrials.gov/show/NCT00031070?order=133
Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. T-Lymphocytes, Cytotoxic. Genotype. Species Specificity. Neutralization Tests. Viral Load. Alleles. HLA ... Blood samples are used to assess CD4 counts, plasma viral load, genetic parameters, and individual immune responses. ...https://clinicaltrials.gov/show/NCT00006298?order=77
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Nelfinavir. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Viral Load. remune. Combivir. ...https://clinicaltrials.gov/show/NCT00005002?order=202
The Effects of Illnesses on HIV Levels in the Body - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Polymerase Chain Reaction. RNA, Viral. Fever. Viral Load. Additional relevant MeSH terms: ... To describe changes in phenotypic markers of immune activation/dysregulation of CD4 and CD8 lymphocyte subsets and their ... To identify factors associated with increases, i.e., type of illness ultimately diagnosed (bacterial, viral, fungal), CD4 cell ...https://clinicaltrials.gov/show/NCT00000900?order=214
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3...
CD4 Lymphocyte Count. RNA, Viral. Quality of Life. Anti-HIV Agents. Viral Load. ... The purpose of this study is to examine how rIL-2 affects HIV-positive patients with CD4 counts over 300 cells/mm3 who are on ... A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 ... There is strong evidence that rIL-2 increases CD4 cell counts (cells of the immune system that fight infection). This study ...https://clinicaltrials.gov/show/NCT00000949?order=610
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Antiretroviral Therapy, Highly Active. Growth Hormone. Cell Division. CD4-Positive T-Lymphocytes. ... Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs. This study has been completed. ... This study is designed to evaluate the ability of growth hormone (GH, also known as somatropin) to increase CD4+ cell counts in ... Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, ...https://clinicaltrials.gov/ct2/show/study/NCT00050921?view=results
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy - Full...
CD4 Lymphocyte Count. Disease Progression. Follow-Up Studies. Anti-HIV Agents. Additional relevant MeSH terms: ... Absolute CD4 Cell Counts Averaged Throughout Followup [ Time Frame: from randomization through study end - median of 7.6 years ... Even among patients with apparent virologic control, a 'ceiling effect' seems to exist with failure of CD4 cell counts to rise ... Have a CD4 cell count of 300 cells/mm3 or more within 45 days of study entry ...https://clinicaltrials.gov/ct2/show/study/NCT00004978?term=NCT00004978&show_locs=Y
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background...
CD4 Lymphocyte Count. Ritonavir. Indinavir. Disease Progression. RNA, Viral. Genotype. Nelfinavir. Anti-HIV Agents. Viral Load ... MacArthur RD, Perez G, Walmsley S, Baxter J, Neaton J, Wentworth D. CD4 cell count is a better predictor of disease progression ... A CD4+ cell count ,= 100/mm3 within 3 months prior to the study. [AS PER AMENDMENT 3/11/98: CD4+ cell count ,= 200/mm3 any time ... 1 resistance and to compare changes in plasma HIV RNA levels and CD4+ cell counts in a sample of patients with CD4+ cell counts ...https://clinicaltrials.gov/show/NCT00000859?order=52
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also...
Lymphocytes. Interleukin-2. Drug Therapy, Combination. AIDS Vaccines. CD4 Lymphocyte Count. Cell Division. HIV Core Protein p24 ... Remune has been reported to increase lymphocyte proliferative responses to HIV antigens in patients with high CD4 cell counts. ... Blood and skin tests are performed at Weeks 0, 8, 16, and 24 to measure immune response and lymphocyte proliferative responses. ... Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis ...https://clinicaltrials.gov/show/NCT00000943?order=46
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells...
CD4 Lymphocyte Count. Anti-HIV Agents. Additional relevant MeSH terms: Infection. Communicable Diseases. HIV Infections. ... CD4 cells are cells of the immune system that help fight infection. Anti-HIV therapy may increase CD4 counts, which may lead to ... especially in those whose CD4 counts drop below 50 cells/mm3. It will also allow assessment of the levels of CD4 cell number at ... Have had an increase in CD4 cell count from less than or equal to 50 cells/mm3 to over 100 cells/mm3 on 2 separate occasions, ...https://clinicaltrials.gov/show/NCT00000883?order=13
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Polymerase Chain Reaction. Enzyme-Linked Immunosorbent Assay. RNA, Messenger. Interleukin-1. Body ... CD4 cell counts, height, and weight in HIV-infected children. This study also compares changes in body composition to levels of ... If this is true, body composition measurements can be as useful as CD4+ cell counts in determining drug effectiveness. ... persistent CD4+ cell count changes. Additionally, if body composition changes are highly correlated with responses in viral ...https://clinicaltrials.gov/show/NCT00006064?order=213
Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs - Full Text View - ClinicalTrials.gov
CD4 Lymphocyte Count. Risk Factors. Hydroxyurea. Disease Progression. Alcohol Drinking. Reverse Transcriptase Inhibitors. Anti- ... and peripheral blood lymphocyte analysis for quantitation of mitochondrial DNA content at entry and final study visit. ... such as CD4+ cell counts, HIV-1 viral load, and prior nucleoside analogue use, will be evaluated. The potential additive ...https://clinicaltrials.gov/show/NCT00017771?order=80